US-based ViewRay, a designer and manufacturer of the MRIdian radiation therapy system, has won French tender for MR image-guided radiation therapy.
ViewRay’s MRIdian Linac has been selected to install at Centre Georges-François Leclerc (CGFL) in Dijon, France as part of a tender award contract with UNICANCER, a hospital network of 19 French Comprehensive Cancer Centers (FCCCs).
MRIdian Linac integrates the latest innovations in precision radiation delivery with MR image guidance.
CGFL said MRIdian Linac’s ability to offer adaptive radiotherapy helps it overcome challenges such as real-time anatomical movement and day-to-day changes in the shape, size or location of the tumor.
With the daily real-time on-table adaptive radiotherapy treatment, the system allows clinicians to rapidly adjust for anatomical changes that could naturally occur every day throughout the patient’s course of treatment.
The technology also enables oncologists to visualize and actively track the tumor’s contours and surrounding organs during radiation delivery with the help of a non-ionizing, streaming video perspective.
The combined capabilities offer the clinicians with the tools to potentially enhance tumor targeting precision and allow for delivery of higher, and with possible effective radiation doses.
UNICANCER, which is dedicated to oncology, promotes oncology clinical trials in Europe. Its FCCCs enable for quick and secure access to innovations in the areas of care and research.
CGFL head of clinical R&D for radiation therapy Gilles Créhange said: “By integrating MRI with a Linac, ViewRay has foreseen the future of external radiotherapy, which is linked to improvements in target and organ definition based on the anatomy of the day using MRI.
“Targeting cancer and delivering radiation under real-time MRI guidance should improve treatment with the potential for lower rates of toxicity.”
ViewRay’s MRIdian is built upon a high-definition MR imaging system designed from the ground up to address the challenges and clinical workflow for advanced radiation oncology.
The system’s high-definition MR is designed to address particular challenges, including beam distortion, skin toxicity, and other concerns that could possibly arise when high magnetic fields interact with radiation beams.